BCL6 and medulloblastoma: In most cases, BCL6 expression is associated with poor prognosis and worse outcome, although not always—BCL6 can suppress tumorigenesis in medulloblastoma [10] and is associated with a better prognosis in a subset of gastric lymphoma [11].